BCRX

BioCryst Pharmaceuticals (BCRX)

BioCryst Pharmaceuticals Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:BCRX

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/09/17	20 : 00	GlobeNewswire Inc.	BioCryst and the pan-Canadian Pharmaceutical Alliance (pCPA) Successfully Complete Negotiations for ORLADEYO® (berotralstat), an Oral, Once-daily Therapy for the Prevention of Hereditary Angioedema Attacks	NASDAQ:BCRX	BioCryst Pharmaceuticals Inc
2024/09/11	01 : 09	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:BCRX	BioCryst Pharmaceuticals Inc
2024/09/06	15 : 00	GlobeNewswire Inc.	BioCryst Presents New ORLADEYO® (berotralstat) Data at 7th Bradykinin Symposium	NASDAQ:BCRX	BioCryst Pharmaceuticals Inc
2024/09/05	20 : 00	GlobeNewswire Inc.	BioCryst Appoints Dr. Donald Fong Chief Medical Officer	NASDAQ:BCRX	BioCryst Pharmaceuticals Inc
2024/09/04	20 : 00	GlobeNewswire Inc.	BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:BCRX	BioCryst Pharmaceuticals Inc
2024/09/04	05 : 17	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BCRX	BioCryst Pharmaceuticals Inc
2024/08/22	20 : 00	GlobeNewswire Inc.	BioCryst to Present at Upcoming Investor Conferences	NASDAQ:BCRX	BioCryst Pharmaceuticals Inc
2024/08/07	05 : 38	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:BCRX	BioCryst Pharmaceuticals Inc
2024/08/05	20 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BCRX	BioCryst Pharmaceuticals Inc
2024/08/05	20 : 00	GlobeNewswire Inc.	BioCryst Reports Second Quarter 2024 Financial Results and Provides Business Update	NASDAQ:BCRX	BioCryst Pharmaceuticals Inc
2024/08/05	18 : 46	IH Market News	U.S. Index Futures and Oil Prices Plunge on Recession Concerns	NASDAQ:BCRX	BioCryst Pharmaceuticals Inc
2024/08/02	20 : 00	GlobeNewswire Inc.	BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:BCRX	BioCryst Pharmaceuticals Inc
2024/07/22	20 : 00	GlobeNewswire Inc.	BioCryst to Report Second Quarter 2024 Financial Results on August 5	NASDAQ:BCRX	BioCryst Pharmaceuticals Inc
2024/07/02	20 : 00	GlobeNewswire Inc.	BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:BCRX	BioCryst Pharmaceuticals Inc
2024/06/18	05 : 31	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BCRX	BioCryst Pharmaceuticals Inc
2024/06/18	05 : 14	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:BCRX	BioCryst Pharmaceuticals Inc
2024/06/15	05 : 33	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BCRX	BioCryst Pharmaceuticals Inc
2024/06/15	05 : 31	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BCRX	BioCryst Pharmaceuticals Inc
2024/06/15	05 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BCRX	BioCryst Pharmaceuticals Inc
2024/06/15	05 : 28	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BCRX	BioCryst Pharmaceuticals Inc
2024/06/15	05 : 27	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BCRX	BioCryst Pharmaceuticals Inc
2024/06/15	05 : 25	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BCRX	BioCryst Pharmaceuticals Inc
2024/06/15	05 : 23	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BCRX	BioCryst Pharmaceuticals Inc
2024/06/15	05 : 20	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BCRX	BioCryst Pharmaceuticals Inc
2024/06/15	05 : 18	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BCRX	BioCryst Pharmaceuticals Inc
2024/06/15	05 : 08	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:BCRX	BioCryst Pharmaceuticals Inc
2024/06/14	05 : 23	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BCRX	BioCryst Pharmaceuticals Inc
2024/06/04	20 : 00	GlobeNewswire Inc.	BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:BCRX	BioCryst Pharmaceuticals Inc
2024/06/04	05 : 33	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BCRX	BioCryst Pharmaceuticals Inc
2024/06/04	05 : 29	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BCRX	BioCryst Pharmaceuticals Inc